Axxess AGILE Conference to Highlight AI Innovations in Home Care and Leadership Development
- Axxess hosts the AGILE conference focused on AI integration in home care from May 4-6, 2026, in Dallas.
- The conference introduces the EDGE Leadership Certification to enhance leadership skills in home health sectors.
- Axxess aims to inspire home care innovation and collaboration through the AGILE 2026 Distinction Awards and continuing education opportunities.
Axxess AGILE Conference to Explore AI in Home Care Innovation
Axxess, a trailblazer in transforming home care delivery through technology, gears up for its 2026 Axxess Growth, Innovation and Leadership Experience (AGILE) event from May 4-6 at the Fairmont Hotel in Dallas. This year's conference will delve into the integration of artificial intelligence and emerging technologies within the healthcare landscape, with keynote presentations from industry luminaries Dr. Geeta Nayyar and Dave Copps. Dr. Nayyar, a physician-technologist and bestselling author, along with Copps, CEO of Worlds and an AI visionary, will explore how a people-centered approach can capitalize on technological advancements to improve healthcare delivery and patient outcomes.
The AGILE conference introduces the Essentials in Driving Growth and Excellence (EDGE) Leadership Certification, a new program aimed at bolstering leadership capabilities among professionals in home health, hospice, and home care sectors. This intensive four-hour course involves case studies, interactive scenario discussions, and knowledge checks to enhance skills crucial for navigating the evolving landscape of home care services. Tammy Ross, Axxess’s Executive Vice President of Professional Services, emphasizes that the industry's pivot towards a stronger focus on defining challenges and leveraging AI for growth, outcomes enhancement, and compliance signifies a monumental shift in provider perspectives.
In conjunction with these discussions and workshops, the AGILE 2026 Distinction Awards will pay tribute to esteemed figures in the home care sphere. This year, the David Merk Enduring Legacy Award will honor Bill Dombi, the former president of the National Association for Home Care and Hospice, acknowledging his impactful contributions to the advancement of home care. As registration opens for care at home professionals, Axxess aims to foster a vibrant exchange of ideas and practical strategies at AGILE, pushing the boundaries of innovation in home care.
In related developments, the AGILE conference not only seeks to inspire leaders but also offers participants the opportunity to earn up to 30 continuing education units, ensuring that the skills learned can be immediately applied to enhance organizational effectiveness. Professionals interested in attending can register and find additional information at Axxess's dedicated event website, reinforcing the importance of continuous education in an ever-evolving healthcare landscape.
Overall, the AGILE conference serves as a vital platform for fostering innovation and collaboration among home care providers, encouraging the adoption of new technologies to meet present and future challenges in the industry.
Related Cashu News

Bristol-Myers Squibb's Reclassification Enhances Growth Potential in Defensive Investment Strategy
Bristol-Myers Squibb Company (Ticker: BMY) undergoes a key reclassification across the Russell indexes, marking a transformative moment for the company. Moving to the Russell 1000 Defensive and Russel…

Vertex Pharmaceuticals' Casgevy Gains FDA Approval for Expanded Sickle Cell Disease Treatment Options
Vertex Pharmaceuticals (Ticker: VRTX) receives a significant boost in its ongoing battle against sickle cell disease with the recent FDA approval of an expanded label for its gene therapy product, Cas…

Gilead Sciences Gains FDA Approval for Trodelvy in First-Line Triple-Negative Breast Cancer Treatment
Gilead Sciences (Ticker: GILD) makes significant strides in oncology therapy with the recent approval of its drug Trodelvy for patients with unresectable or metastatic triple-negative breast cancer. T…

Merck Advances HIV Treatment and Faces Regulatory Scrutiny Amidst Market Success
Merck & Co. (Ticker: MRK) has recently made significant strides in the pharmaceutical landscape, particularly with its advancements in HIV treatment. The company's innovative drug, IDVYNSO, has receiv…

